Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Frontida BioPharma Appoints EVP Technology | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Frontida BioPharma Appoints EVP Technology

Dr. Praful Agrawala brings years of pharmaceutical product development leadership experience to the company.

By: Contract Pharma

Contract Pharma Staff

Frontida BioPharm Inc., a pharmaceutical contract development and manufacturing organization (CDMO) based in the Philadelphia and Chicago areas, has appointed Praful Agrawala, Ph.D., as executive vice president, Technology. Agrawala adds years of pharmaceutical product development leadership experience to Frontida after serving in executive roles at Amneal Pharmaceuticals, Sanofi-Aventis, and Schering-Plough Research Institute.
 
Agrawala’s core competencies include product development, discovery research interfacing, preclinical evaluation, clinical and CMC development of new chemical entities, inhalation product development, drug-device combinations development, manufacturing process development and commercialization, contract development & manufacturing, licensing, alliance management and platform technology evaluations.
 
Experience
 
Agrawala joins Frontida with a noteworthy scientific background including experience in multiple dosage form development of long-acting injectables, sterile solutions, MDI and DPI inhalation products and devices, modified release tablets, rapidly disintegrating tablets, oral and nasal suspensions, oral solutions, semi-solids and transdermal products.
 
Anthony Qu, Frontida’s COO, commented, “Dr. Agrawala’s proven track record in developing complex formulations of long-acting and immediate release injectables, inhalation and oral dosage forms showcases his extensive background in pharmaceutics, quality and regulatory aspects of branded and generic product development. Our team is excited to have Dr. Agrawala join us during this intensive growth phase at Frontida.”
 
In response, Dr. Agrawala said, “I am delighted to join Frontida Biopharm at this time of tremendous growth for the company. I look forward to working with the teams at Frontida to advance the company’s broad portfolio of drug delivery technologies, product development and manufacturing services for pharmaceutical companies.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters